Life Sciences

FDA: HUMIRA ad misleading

Pharma Compliance Alert, December 31, 2008

Abbott’s American Academy of Dermatology post meeting news ad for HUMIRA misbrands the drug in violation of the Food, Drug, and Cosmetic Act, according to an FDA warning letter.

Post a Comment

Name:

 

E-mail:

 

Please enter your comment below:

   

Please enter the text below:

   
   

Most Popular